✦ LIBER ✦

LONG-TERM OUTCOME OF THE UNRESTRICTED USE OF EVEROLIMUS-ELUTING STENTS COMPARED TO SIROLIMUS-ELUTING STENTS AND PACLITAXEL-ELUTING STENTS IN DIABETIC PATIENTS: THE BERN-ROTTERDAM DIABETES COHORT STUDY

✍ Scribed by Simsek, Cihan; Raber, Lorenz; Magro, Michael; Boersma, Eric; Onuma, Yoshinobu; Stefanini, Giulio; Kalesan, Bindu; Wenaweser, Peter; Geuns, Robert Van; Juni, Peter; Domburg, Ron Van; Windecker, Stephan; Serruys, Patrick

Book ID: 122267156
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 267 KB
Volume: 59
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(12)61534-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term outcome of the unrestricted us

Long-term outcome of the unrestricted use of everolimus-eluting stents compared to sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients: The Bern–Rotterdam diabetes cohort study

✍ Simsek, C.; Räber, L.; Magro, M.; Boersma, E.; Onuma, Y.; Stefanini, G.G.; Zanch 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 556 KB

Outcomes After Unrestricted Use of Evero

Outcomes After Unrestricted Use of Everolimus-Eluting Stent Compared to Paclitaxel- and Sirolimus-Eluting Stents

✍ Michael Mahmoudi; Cedric Delhaye; Kohei Wakabayashi; Itsik Ben-Dor; Manuel A. Go 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 264 KB

Clinical outcomes following unrestricted

Clinical outcomes following unrestricted use of the everolimus-eluting stent as compared with paclitaxel- and sirolimus-eluting stents

✍ Michael Mahmoudi; Cedric Delhaye; Kohei Wakabayashi; Itsik Ben-Dor; Manuel A. Go 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Clinical outcomes following unrestricted

Clinical outcomes following unrestricted use of the everolimus-eluting stent as compared with paclitaxel- and sirolimus-eluting stents

✍ Michael Mahmoudi; Cedric Delhaye; Kohei Wakabayashi; Itsik Ben-Dor; Manuel A. Go 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

CLINICAL OUTCOMES FOLLOWING UNRESTRICTED

CLINICAL OUTCOMES FOLLOWING UNRESTRICTED USE OF THE EVEROLIMUS-ELUTING STENT AS COMPARED WITH PACLITAXEL- AND SIROLIMUS-ELUTING STENTS

✍ Mahmoudi, Michael; Delhaye, Cedric; Wakabayashi, Kohei; Ben-Dor, Itsik; Gonzalez 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 118 KB

TCT-41 The Impact of Left Main Disease o

TCT-41 The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting Stents: A Substudy of the Bern-Rotterdam Cohort

✍ Aris Moschovitis; Giulio Stefanini; Michael Magro; Lorenz Räber; Bindu Kalesan; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 86 KB